HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daisuke Nakatsubo Selected Research

Deep Brain Stimulation

1/2022A case report: Dual-lead deep brain stimulation of the posterior subthalamic area and the thalamus was effective for Holmes tremor after unsuccessful focused ultrasound thalamotomy.
12/2021Instability of speech in Parkinson disease patients with subthalamic nucleus deep brain stimulation.
11/2021Techniques, Indications, and Outcomes in Magnetic Resonance-guided Focused Ultrasound Thalamotomy for Tremor.
1/2020Longitudinal Speech Change After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease Patients: A 2-Year Prospective Study.
12/2017Early detection of speech and voice disorders in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation: a 1-year follow-up study.
10/2016Articulation Features of Parkinson's Disease Patients with Subthalamic Nucleus Deep Brain Stimulation.
1/2015Installation of a Neuromate Robot for Stereotactic Surgery: Efforts to Conform to Japanese Specifications and an Approach for Clinical Use-Technical Notes.
1/2012Preoperative regional cerebral blood flow and postoperative clinical improvement in patients with Parkinson's disease undergoing subthalamic nucleus deep brain stimulation.
11/2009Changes in regional blood flow induced by unilateral subthalamic nucleus stimulation in patients with Parkinson's disease.
6/2009Staged bilateral deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daisuke Nakatsubo Research Topics

Disease

8Parkinson Disease (Parkinson's Disease)
12/2021 - 06/2009
3Speech Disorders (Cluttering)
01/2020 - 10/2016
2Tremor (Tremors)
01/2022 - 11/2021
2Dysarthria (Spastic Dysarthria)
06/2019 - 12/2017
2Stuttering (Stammering)
06/2019 - 12/2017
1Rhinosinusitis
03/2024
1Asthma (Bronchial Asthma)
03/2024
1Nasal Polyps (Nasal Polyp)
03/2024
1Pathologic Constriction (Stenosis)
01/2023
1Ulcer
01/2023
1Deglutition Disorders (Dysphagia)
01/2023
1COVID-19
11/2022
1Pathologic Processes
11/2022
1Essential Tremor (Essential Tremors)
11/2021
1Epilepsy (Aura)
10/2018
1Neuralgia (Stump Neuralgia)
10/2018
1Voice Disorders (Voice Disturbances)
12/2017
1Cerebrospinal Fluid Leak
01/2015

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
03/2024 - 11/2022
2Biomarkers (Surrogate Marker)IBA
03/2024 - 11/2022
2Iofetamine (Iofetamine Hydrochloride, I 123)IBA
01/2012 - 11/2009
1Eosinophil PeroxidaseIBA
03/2024
1ColchicineFDA LinkGeneric
01/2023
1Prednisolone (Predate)FDA LinkGeneric
01/2023
1Infliximab (Remicade)FDA Link
01/2023
1RNA (Ribonucleic Acid)IBA
11/2022
1Levodopa (L Dopa)FDA LinkGeneric
06/2019
1Iodine-123IBA
01/2012

Therapy/Procedure

10Deep Brain Stimulation
01/2022 - 06/2009
1Diet Therapy (Therapy, Diet)
01/2023
1Ultrasonic Therapy
01/2022
1Ultrasonic Surgical Procedures
11/2021
1Activities of Daily Living (ADL)
06/2019
1Craniotomy
10/2018
1Spinal Cord Stimulation
10/2018